Your browser doesn't support javascript.
loading
Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking.
Kanhasut, Karnpob; Tharakaraman, Kannan; Ruchirawat, Mathuros; Satayavivad, Jutamaad; Fuangthong, Mayuree; Sasisekharan, Ram.
Afiliação
  • Kanhasut K; Program in Applied Biological Sciences, Chulabhorn Graduate Institute, 54 Kamphaeng Phet 6 Rd, Bangkok, 10210, Thailand.
  • Tharakaraman K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Ruchirawat M; Translational Research Unit, Chulabhorn Research Institute, Bangkok, 10210, Thailand.
  • Satayavivad J; Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, Bangkok, Thailand.
  • Fuangthong M; Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, Bangkok, Thailand.
  • Sasisekharan R; Laboratory of Pharmacology, Chulabhorn Research Institute, 54 Kamphaeng Phet 6 Rd, Bangkok, 10210, Thailand.
Sci Rep ; 12(1): 14754, 2022 08 30.
Article em En | MEDLINE | ID: mdl-36042241
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alanina / Raquitismo Hipofosfatêmico Familiar Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Animals / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alanina / Raquitismo Hipofosfatêmico Familiar Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Animals / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article